Skip to main content
. 2023 Oct 23;15(20):4487. doi: 10.3390/nu15204487

Table 3.

Differences in selected parameters between patients with different diagnoses.

Variable CCS STEMI NSTEMI UA p-Value
N 206 107 59 32 -
Age (years) 64.3 (30.9–93.3) 59.8 (36.3–88.4) 61.5 (38.0–86.4) 66.5 (33.6–80.8) <0.001
BMI (kg/m2) 27.8 (16.1–47.4) 27.0 (16.9–44.6) 27.9 (20.8–36.1) 26.4 (22.2–34.6) 0.24
Previous MI (no/yes) 130/76 60/47 26/33 20.12 0.06
CASSS (0/1/2/3) 62/43/57/44 3/50/31/23 5/17/19/18 2/5/11/14 <0.001
Total cholesterol (mg/dL) 164 (96–327) 180 (98–320) 165 (70–334) 144 (81– 303) 0.002
High-density lipoprotein (mg/dL) 46.0 (14.6–113) 44.3 (20.5–92.9) 39.3 (22.8–73.2) 42.8 (19.5–65.8) <0.001
Low-density lipoprotein (mg/dL) 86.2 (22.3–258) 107 (38.2–214) 96.4 (23.5–244) 75.5 (32.9–228) <0.001
Triglycerides (mg/dL) 113 (37–438) 108 (55–368) 115 (44–457) 109 (43–252) 0.49
Hyperlipidemia (no/yes) 91/115 35/72 23/36 21/11 0.008
Hypertension (no/yes) 44/162 20/87 8/51 1/31 0.07
Smoking (no/ex-smokers/yes) 119/37/50 45/7/55 27/3/29 22/6/4 <0.001
Type 2 diabetes mellitus (yes/pre-diabetes/no) 116/10/79 75/3/28 37/4/18 18/0/14 0.15
Monocytes (thousand cells/µL) 0.73 (0.30–1.76) 0.80 (0.31–1.63) 0.68 (0.40–1.65) 0.76 (0.31–1.54) 0.06
MHR 0.015 (0.01–0.06) 0.018 (0.01–0.06) 0.017 (0.01–0.05) 0.018 (0.01–0.07) 0.009
Serum 25(OH)D (ng/mL) 16.8 (4.1–46.9) 14.1 (4.0–42.9) 14.0 (5.0–37.6) 17.6 (4.3–36.7) 0.035
Examination date (May–October/November–April) 51/155 28/79 17/42 10/22 0.84

Data presented as number or median (range). CCS—chronic coronary syndrome; BMI—body mass index; MI—myocardial infarction; CASSS—Coronary Artery Surgery Study Score; MHR—monocyte-to-high-density lipoprotein ratio; prevalence differences between groups were determined using Pearson’s chi-squared test or Fisher’s exact test; Kruskal–Wallis one-way ANOVA followed by Dunn’s post hoc test for multiple comparisons was used to determine the dependence between groups.